187 related articles for article (PubMed ID: 30477410)
1. Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line.
Campos JR; Fernandes AR; Sousa R; Fangueiro JF; Boonme P; Garcia ML; Silva AM; Naveros BC; Souto EB
Pharm Dev Technol; 2019 Jun; 24(5):616-622. PubMed ID: 30477410
[TBL] [Abstract][Full Text] [Related]
2. Development and Optimization of Alpha-Pinene-Loaded Solid Lipid Nanoparticles (SLN) Using Experimental Factorial Design and Dispersion Analysis.
Zielińska A; Ferreira NR; Durazzo A; Lucarini M; Cicero N; Mamouni SE; Silva AM; Nowak I; Santini A; Souto EB
Molecules; 2019 Jul; 24(15):. PubMed ID: 31344802
[TBL] [Abstract][Full Text] [Related]
3. Development of Houttuynia cordata Extract-Loaded Solid Lipid Nanoparticles for Oral Delivery: High Drug Loading Efficiency and Controlled Release.
Kim JH; Baek JS; Park JK; Lee BJ; Kim MS; Hwang SJ; Lee JY; Cho CW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29236057
[No Abstract] [Full Text] [Related]
4. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
Soares S; Fonte P; Costa A; Andrade J; Seabra V; Ferreira D; Reis S; Sarmento B
Int J Pharm; 2013 Nov; 456(2):370-81. PubMed ID: 24036086
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach.
Makwana V; Jain R; Patel K; Nivsarkar M; Joshi A
Int J Pharm; 2015 Nov; 495(1):439-446. PubMed ID: 26367780
[TBL] [Abstract][Full Text] [Related]
6. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
[TBL] [Abstract][Full Text] [Related]
7. Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.
Nazief AM; Hassaan PS; Khalifa HM; Sokar MS; El-Kamel AH
Int J Nanomedicine; 2020; 15():1129-1148. PubMed ID: 32110012
[TBL] [Abstract][Full Text] [Related]
8. Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.
Rahman MA; Harwansh RK; Iqbal Z
Pharm Nanotechnol; 2019; 7(2):162-176. PubMed ID: 30919786
[TBL] [Abstract][Full Text] [Related]
9. Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery.
Spada G; Gavini E; Cossu M; Rassu G; Giunchedi P
Nanotechnology; 2012 Mar; 23(9):095101. PubMed ID: 22323085
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles (SLNs) gels for topical delivery of aceclofenac in vitro and in vivo evaluation.
Dasgupta S; Ghosh SK; Ray S; Mazumder B
Curr Drug Deliv; 2013 Dec; 10(6):656-66. PubMed ID: 24274634
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer®.
Zielińska A; Martins-Gomes C; Ferreira NR; Silva AM; Nowak I; Souto EB
Int J Pharm; 2018 Dec; 553(1-2):428-440. PubMed ID: 30385373
[TBL] [Abstract][Full Text] [Related]
12. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery.
Chantaburanan T; Teeranachaideekul V; Chantasart D; Jintapattanakit A; Junyaprasert VB
J Colloid Interface Sci; 2017 Oct; 504():247-256. PubMed ID: 28551519
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
Howard MD; Lu X; Jay M; Dziubla TD
Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.
del Pozo-Rodríguez A; Solinís MA; Gascón AR; Pedraz JL
Eur J Pharm Biopharm; 2009 Feb; 71(2):181-9. PubMed ID: 18940256
[TBL] [Abstract][Full Text] [Related]
16. Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying.
Doktorovova S; Shegokar R; Fernandes L; Martins-Lopes P; Silva AM; Müller RH; Souto EB
Pharm Dev Technol; 2014 Dec; 19(8):922-9. PubMed ID: 24099511
[TBL] [Abstract][Full Text] [Related]
17. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
Teskac K; Kristl J
Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178
[TBL] [Abstract][Full Text] [Related]
18. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
19. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
20. Loading, release profile and accelerated stability assessment of monoterpenes-loaded solid lipid nanoparticles (SLN).
Zielińska A; Ferreira NR; Feliczak-Guzik A; Nowak I; Souto EB
Pharm Dev Technol; 2020 Sep; 25(7):832-844. PubMed ID: 32204628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
